CA9, TFRC and SCD are all risk factors for cervical cancer, so we predicted candidate drugs for these genes, among which 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one and oxygen could regulate all three of these risk factors. This evidence concerns the gene CA9 and cervical carcinoma.